Petros Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%)
Petros Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Mitchell P. Kopin(6.6%),Daniel B. Asher(6.6%)等
Petros Pharmaceuticals | 4:持股变动声明-董事 Bernstein Bruce
Petros Pharmaceuticals | 4:持股变动声明-高管 Boctor Fady
Petros Pharmaceuticals | 4:持股变动声明-董事 WALKER WAYNE REMELL
Petros Pharmaceuticals | 4:持股变动声明-高管 Arnold Mitchell
Petros Pharmaceuticals | 4:持股变动声明-董事 Silverman Joshua
Petros Pharmaceuticals | 4:持股变动声明-董事 Bradley Greg
Petros Pharmaceuticals | D:发行公告
Petros Pharmaceuticals | 4:持股变动声明-董事 Bradley Greg
Petros Pharmaceuticals | 4:持股变动声明-董事 Bernstein Bruce
Petros Pharmaceuticals | 4:持股变动声明-董事 WALKER WAYNE REMELL
Petros Pharmaceuticals | 4:持股变动声明-董事 Silverman Joshua
Petros Pharmaceuticals | 4:持股变动声明-董事 WALKER WAYNE REMELL
Petros Pharmaceuticals | 4:持股变动声明-董事 Silverman Joshua
Petros Pharmaceuticals | 4:持股变动声明-董事 Bradley Greg
Petros Pharmaceuticals | 4:持股变动声明-董事 Bernstein Bruce
Petros Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Mitchell P. Kopin(7.6%),Daniel B. Asher(7.6%)等
Petros Pharmaceuticals | 4:持股变动声明
Petros Pharmaceuticals | 4:持股变动声明
暂无数据